Recent Updates
Recently added Catalysts
IONS Positive Sentiment

Ionis to hold first quarter 2024 financial results webcast Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, May 7th at 11:30 a.m. Eastern Time to discuss ...

Key Takeaway: Ionis Pharmaceuticals, Inc. will host a live webcast on May 7, 2024, at 11:30 a.m. ET to discuss its first quarter financial results. The webcast will be accessible online, and a replay will be available for a limited time. Ionis is recognized for its innovative RNA-targeted medicines and has a robust pipeline.
Price reaction · baseline $41.07 (2024-04-22 close) · hit after-hours · 1 other IONS headline(s) in the window, move may be shared
day 0 close · peak
+1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ionis is hosting a live webcast to discuss financial results.
  • The company has a strong pipeline in neurology and cardiology.
  • Ionis has been a pioneer in RNA-targeted medicines.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
4.1%
average across 11 past catalysts
Lead asset
ISIS 113715
Phase 2 · Type 2 Diabetes Mellitus

Full Press Release Details

Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time
CARLSBAD, Calif. , April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS ) announced today that it will host a live webcast on Tuesday, May 7 th at 11:30 a.m. Eastern Time to discuss its first quarter 2024 financial results.
The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events . A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Frequently Asked Questions

When will Ionis hold its Q1 2024 financial results webcast?

Ionis will host its Q1 2024 financial results webcast on May 7, 2024.

How can I access the Ionis webcast?

The webcast can be accessed at Ionis Pharmaceuticals' investor relations website.

What is Ionis known for?

Ionis is known for its pioneering work in RNA-targeted medicines and its strong pipeline.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available for a limited time.

Last updated: Apr 23, 2024